Literature DB >> 8602018

Tamoxifen and menopausal status: risks and benefits.

A J Sasco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8602018     DOI： 10.1016/s0140-6736(96)90111-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Adjuvant treatment with tamoxifen. Local research ethics committees should review their approval of prevention trial.

Authors:  C Read
Journal:  BMJ       Date:  1996-04-20

2.  The Prescription Pattern of Chinese Herbal Products Containing Ginseng among Tamoxifen-Treated Female Breast Cancer Survivors in Taiwan: A Population-Based Study.

Authors:  Wei-Lung Hsu; Yueh-Ting Tsai; Chien-Tung Wu; Jung-Nien Lai
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-01       Impact factor: 2.629

3.  The prescription pattern of Chinese herbal products that contain dang-qui and risk of endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan: a population-based study.

Authors:  Chien-Tung Wu; Jung-Nien Lai; Yueh-Ting Tsai
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.